Real-World Data, Real-World Impact

Run Time

15 minutes
rwd-after-dark-logo

This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance Wolkenbrod discussing how integrated real-world data (RWD) is improving patient access to therapies in multiple myeloma. By combining claims, EMR, lab, mortality, and physician note data, Norstella developed clinical profiles that helped identify patients at key disease stages and match them to appropriate therapies faster. The discussion highlights how AI, clinical expertise, and cross-functional collaboration transformed complex healthcare data into actionable insights, ultimately contributing to more than 800 new patient starts and improving treatment decisions and patient outcomes.

Frequently asked questions

What types of data are included in Norstella’s RWD ecosystem?
Norstella’s ecosystem integrates open and closed claims, EMR data, social determinants of health (SDOH), mortality data, and lab data into a connected, tokenized dataset that supports longitudinal patient tracking.
How does integrated RWD improve patient identification in multiple myeloma?
By combining multiple data sources, Norstella can identify patients at different stages of their disease journey, including newly diagnosed, relapsed/refractory, and high-risk patients, helping providers make faster and more informed treatment decisions.
What are clinical profiles and why are they important?
Clinical profiles are data-driven patient segments built around disease stage, treatment history, biomarkers, and risk factors. These profiles help life sciences organizations better match patients to appropriate therapies and engage providers at the right time.
How does EMR and physician note data enhance traditional claims analysis?
Traditional claims data shows what treatments occurred, while EMR data and physician notes help explain why treatment changes happened, including factors like toxicity, treatment discontinuation, or physician decision-making.

Dive into the series

Real-world data can be complex, but it doesn’t have to be. Real-World Data After Dark blends deep insights with light late-night talk show banter. Our experts unpack complex challenges, spark new ideas, and show how real-world data shapes pharma strategy and drives better patient outcomes—with a twist.
Daniel-Chancellor
Dan Chancellor
VP, Thought Leadership, Norstella
madeline-naylor-headshot
Dr. Madeline Naylor, DHSc, MMS, CCRP
Chief Clinician, Norstella
lance-wolkenbrod-headshot
Lance Wolkenbrod
Senior Principal, Real-World Data Solutions, Norstella

Norstella Brands